Skip to main content
. 2022 Mar 14;11(3):551. doi: 10.3390/antiox11030551

Table 6.

Lipid peroxidation compounds in AD prognosis evaluation.

Lipids p Value
(Kruskal-Wallis Test)
PGs a PGE2 0.11
PGF 0.36
15-E2t-IsoP 0.71
15-F2t-IsoP 0.03 *
IsoPs a 15(R)-15-F2t-IsoP 0.17
2,3-dinor-15-epi-15-F2t-IsoP 0.71
15-keto-15-E2t-IsoP 0.22
15-keto-15-F2t-IsoP 0.08
5-F2t-IsoP 0.19
Total IsoPs 0.02 *
IsoFs a Total IsoFs 0.01 *
NeuroPs b 4(RS)-4-F4t-NeuroP 0.65
10-epi-10-F4t-NeuroP 0.23
14(RS)-14-F4t-NeuroP 0.03 *
Total NeuroPs 0.94
NeuroFs b Total NeuroFs 0.03 *
Dihomo-IsoPs c 1a,1b-dihomo-PGF2α 0.13
Ent-7(RS)-7-F2t-dihomo-IsoP 0.06
17-F2t-dihomo-IsoP 0.13
17-epi-17-F2t-dihomo-IsoP 0.86
Dihomo-IsoFs c 17(RS)-10-epi-SC-Δ15-11-dihomo-IsoF 0.15
7(RS)-ST-Δ8-11-dihomo-IsoF 0.43

Notes: a = Lipids derived from the oxidation of AA; b = Lipids derived from the oxidation of DHA; c = Lipids derived from the oxidation of AdA; * p value < 0.05.